By Editor • September 3, 2026 • 1 min read
The FDA is allowing select developers to introduce generative AI-driven medical devices to the market under a new pilot program.
Among the first participants are Cadence and Limbic, as part of the TEMPO initiative aimed at enhancing digital health technologies for Medicare beneficiaries managing chronic conditions.
Source: www.statnews.com
By Editor • September 3, 2026 • 1 min read
The FDA has surprisingly made progress against unproven stem cell treatments, despite concerns raised by Robert F. Kennedy Jr.'s admissions.
Read moreBy Editor • September 3, 2026 • 2 min read
Experts at the 'Act For Nutrition' conference in Islamabad urge urgent reforms to address Pakistan's nutrition crisis, with malnutrition costing the nation $17 billion yearly.
Read moreBy Editor • September 3, 2026 • 1 min read
U.S. drug overdose deaths saw a significant 27% reduction in 2024, with further declines expected in 2025, mirroring trends in Scotland and Canada.
Read more
